Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Deep vein thrombosis. Show all posts
Showing posts with label Deep vein thrombosis. Show all posts
Tuesday, January 26, 2016

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

›
In continuation of my update on  rivaroxaban Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer Health...
Wednesday, October 2, 2013

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

›
In continuation of my update on Rivaroxaban The EINSTEIN-PE study was an open-label, randomized, non-inferiority trial. The tria...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.